Diridavumab
Diridavumab (CR6261) (INN ) is a monoclonal antibody designed for the treatment of influenza A.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Diridavumab (CR6261) (INN ) is a monoclonal antibody designed for the treatment of influenza A. This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1187849230 under CC BY-SA 4.0; modifications have been made.